Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology MFM
- Sickle cell disease.Lancet. 2017; 390: 311-323
- Mortality in sickle cell disease. Life expectancy and risk factors for early death.N Engl J Med. 1994; 330: 1639-1644
- Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis.Blood. 2015; 125: 3316-3325
- Morbidity associated with sickle cell disease in pregnancy.Am J Obstet Gynecol. 2008; 199 (125.e1–5)
- American College of Obstetricians, Gynecologists’ Committee on Practice Bulletins—Obstetrics. Prediction and prevention of spontaneous preterm birth: ACOG Practice Bulletin, Number 234.Obstet Gynecol. 2021; 138: e65-e90
- Epidemiology and causes of preterm birth.Lancet. 2008; 371: 75-84
- Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000.Obstet Gynecol. 2005; 105: 1084-1091
- 96 preterm birth disparities at a single United States academic institution during the COVID pandemic.Am J Obstet Gynecol. 2021; 224: 68S
- Fetal growth restriction: ACOG Practice Bulletin, Number 227.Obstet Gynecol. 2021; 137: e16-e28
- Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222.Obstet Gynecol. 2020; 135: e237-e260
- Five-minute Apgar score as a marker for developmental vulnerability at 5 years of age.Arch Dis Child Fetal Neonatal Ed. 2016; 101: F114-F120
- Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia.Am J Obstet Gynecol. 2001; 184: 1127-1130
- Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease.Obstet Gynecol. 1996; 87: 199-204
- Understanding spontaneous preterm birth: from underlying mechanisms to predictive and preventive interventions.Reprod Sci. 2013; 20: 1274-1292
- Infection in sickle cell disease: a review.Int J Infect Dis. 2010; 14: e2-e12
- Preeclampsia: an endothelial cell disorder.Am J Obstet Gynecol. 1989; 161: 1200-1204
- Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways.Am J Obstet Gynecol. 2022; 226: S907-S927
- Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions.Am J Hematol. 2009; 84: 618-625
A.H.J. received research funding from Coagulant Therapeutics and consulting fees from Octapharma, Cerus Corporation, HemoSonics, and Coagulant Therapeutics. S.M.W. is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) (award number 1KL2TR002554). This funding agency had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; or decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
The authors report no funding for this study.
Cite this article as: Fashakin V, Weber JM, Truong T, et al. Sickle cell disease and the incidence and etiology of preterm birth. Am J Obstet Gynecol MFM 2022;XX:x.ex–x.ex.